New results suggest that triple antiplatelet therapy for patients undergoing percutaneous coronary intervention with drug-eluting stents achieves greater platelet inhibition than conventional dual antiplatelet therapy.
New results suggest that triple antiplatelet therapy for patients undergoing percutaneous coronary intervention with drug-eluting stents achieves greater platelet inhibition than conventional dual antiplatelet therapy.